Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study (Q73208431)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11085688 AND SRC:MED&resulttype=core&format=json

2 November 2019

title

Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11085688 AND SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

systemic lupus erythematosus

0 references

stem cell transplantation

1 reference

A E Traynor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11085688 AND SRC:MED&resulttype=core&format=json

2 November 2019

J Schroeder

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11085688 AND SRC:MED&resulttype=core&format=json

2 November 2019

R M Rosa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11085688 AND SRC:MED&resulttype=core&format=json

2 November 2019

D Cheng

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11085688 AND SRC:MED&resulttype=core&format=json

2 November 2019

J Stefka

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11085688 AND SRC:MED&resulttype=core&format=json

2 November 2019

S Mujais

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11085688 AND SRC:MED&resulttype=core&format=json

2 November 2019

S Baker

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11085688 AND SRC:MED&resulttype=core&format=json

2 November 2019

R K Burt

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11085688 AND SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11085688 AND SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11085688 AND SRC:MED&resulttype=core&format=json

2 November 2019

volume

356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11085688 AND SRC:MED&resulttype=core&format=json

2 November 2019

issue

9231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11085688 AND SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

701-707

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11085688 AND SRC:MED&resulttype=core&format=json

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

Why do patients with lupus nephritis die?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

Evolving spectrum of mortality and morbidity in SLE

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

Participation of the CD69 antigen in the T-cell activation process of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

The role of transforming growth factor beta in the generation of suppression: an interaction between CD8 T and NK cells

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

Genetic dissection of lupus nephritis in murine models of SLE.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

Prevention of development of autoimmune disease in BXSB mice by mixed bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT)

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

Monozygotic twins discordant for systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

A revised estimate of twin concordance in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

Hematopoietic Stem-Cell Transplantation for Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

Control of severe systemic lupus erythematosus after high-dose immunusuppressive therapy and transplantation of CD34 purified autologous stem cells from peripheral blood

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

Autologous peripheral blood stem and progenitor (CD34 ) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

Impaired delayed hypersensitivity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

Abnormalities of delayed hypersensitivity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)02627-1

7 January 2021

10.1016/S0140-6736(00)02627-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11085688 AND SRC:MED&resulttype=core&format=json

2 November 2019

1 reference